CELLERON THERAPEUTICS
An innovative oncology healthcare company The future of cancer therapy lies in the ability to match patients to treatments they will respond favourably to. Celleron has developed biomarkers using epigenetic techniques that match drugs to responsive disease. Their portfolio of technologies can be used to develop a new class of mechanism-based cancer drugs. Drugs that will improve the success rates of treatment, reduce the side effects in patients and deliver more cost effective healthcare.
CELLERON THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2005-01-01
Address:
Abingdon, Oxfordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cellerontherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
4407766255216
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Acthera Therapeutics
Acthera Therapeutics is developing an innovative nanotechnology-based platform for the controlled and targeted drug delivery
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
InProTher
InProTher is an immuno therapy company dedicated to developing the world’s first adaptive immune therapy.
Current Employees Featured
Founder
Investors List
KTB Network
KTB Network investment in Venture Round - Celleron Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Venture Round - Celleron Therapeutics
NHN Investment
NHN Investment investment in Venture Round - Celleron Therapeutics
IMM Investment
IMM Investment investment in Venture Round - Celleron Therapeutics
Official Site Inspections
http://www.cellerontherapeutics.com
- Host name: 95.179.239.122.vultrusercontent.com
- IP address: 95.179.239.122
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1
